761.F

Healthcare Drug Manufacturers - Specialty & Generic

Pharmanutra S.p.A.

€72.50

+1.10 +1.54% today

Price History

Not enough data

Key Stats

Market Cap

694.20M

Avg Volume

P/E (TTM)

33.88

EPS

€2.14

52W High

€94.00

52W Low

€43.75

Div. Yield

1.7%

Valuation

P/B Ratio

9.98

P/S Ratio

4.83

EV/EBITDA

20.69

EV/Revenue

4.78

Margins

Gross Margin 50.3%

Operating Margin 24.6%

Net Margin 14.4%

EBITDA Margin 23.1%

Growth & Returns

Revenue Growth (YoY)

13.3%

Earnings Growth (YoY)

(5.3%)

Earnings Growth (QoQ)

(4.1%)

Return on Equity

31.6%

Return on Assets

16.2%

Liquidity & Leverage

Current Ratio

2.05

Quick Ratio

1.51

Debt / Equity

0.26

Total Cash

15.14M

Total Debt

18.36M

About

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.